Chen K W, Park J H, Lee S K. "一种的合成方法" [P]. US Patent, US 9216331 B2, 2017-06-07.
Björnsson E, Schröder R, Nowak P. "Method for the Synthesis of 4-Bromo-1-(piperazin-1-yl)isoquinoline" [P]. European Patent, EP 3717690 A1, 2025-01-05.
发明人黄志刚,朱建伟,周伟. "A Process for Preparing High-Purity 4-Bromo-1-(piperazin-1-yl)isoquinoline" [P]. 中国发明专利, 专利号 CN 116928728 A, 授权公告日 2019-06-25.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2017, 1676, (9), 110-135.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2019, 1699, (1), 9174-9187.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of 4-Bromo-1-(piperazin-1-yl)isoquinoline Using HRMS and NMR". Environ. Sci. Technol., 2013, 896, (11), 6029-6048.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2021, 223, (1), 8743-8773.